Johnson & Johnson (JNJ) Other Working Capital Changes (2009 - 2026)

Johnson & Johnson (JNJ) posted Other Working Capital Changes of -$349.0 million for Q1 2026, up 76.51% sequentially from -$1.5 billion in Q4 2025, and down 126.5% YoY from $1.3 billion in Q1 2025.

Johnson & Johnson (JNJ) Other Working Capital Changes (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Other Working Capital Changes data on file, last reported at -$349.0 million in Q1 2026.

  • Quarterly Other Working Capital Changes fell 126.5% year-over-year to -$349.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 billion (up 60.81% YoY) and the FY2025 annual result came in at $6.2 billion, up 459.17% from the prior year.
  • Other Working Capital Changes improved to -$349.0 million in Q1 2026 per JNJ's latest filing, from -$1.5 billion in the prior quarter.
  • The five-year high for Other Working Capital Changes was $4.9 billion in Q2 2025, with the low at -$3.2 billion in Q1 2024.
  • Average Other Working Capital Changes over 5 years is $532.1 million, with a median of $229.0 million recorded in 2023.
  • The widest YoY moves for Other Working Capital Changes: up 1153.15% in 2024, down 449.62% in 2024.
  • Johnson & Johnson's Other Working Capital Changes stood at -$995.0 million in 2022, then soared by 312.46% to $2.1 billion in 2023, then sank by 136.33% to -$768.0 million in 2024, then plunged by 93.49% to -$1.5 billion in 2025, then surged by 76.51% to -$349.0 million in 2026.
  • Business Quant data shows JNJ's Other Working Capital Changes at -$349.0 million in Q1 2026, -$1.5 billion in Q4 2025, and $1.5 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 29, 2026 -349.00 Mn
Mar 29, 2026 -349.00 Mn
Mar 29, 2026 -349.00 Mn
Dec 28, 2025 -1.49 Bn
Dec 28, 2025 -1.49 Bn
Dec 28, 2025 -1.49 Bn
Sep 28, 2025 1.46 Bn
Sep 28, 2025 1.46 Bn
Sep 28, 2025 1.46 Bn
Jun 29, 2025 4.88 Bn
Jun 29, 2025 4.88 Bn
Jun 29, 2025 4.88 Bn
Mar 30, 2025 1.32 Bn
Mar 30, 2025 1.32 Bn
Mar 30, 2025 1.32 Bn
Dec 29, 2024 -768.00 Mn
Dec 29, 2024 -768.00 Mn
Dec 29, 2024 -768.00 Mn
Sep 29, 2024 2.78 Bn
Sep 29, 2024 2.78 Bn